Literature DB >> 29280342

Targeted On-line SPE-LC-MS/MS Assay for the Quantitation of 12 Apolipoproteins from Human Blood.

Julia Dittrich1,2, Melanie Adam1, Hilke Maas1, Max Hecht1, Madlen Reinicke1, L Renee Ruhaak3, Christa Cobbaert3, Christoph Engel2,4, Kerstin Wirkner2, Markus Löffler2,4, Joachim Thiery1,2, Uta Ceglarek1,2.   

Abstract

Laborious sample pretreatment of biological samples represents the most limiting factor for the translation of targeted proteomics assays from research to clinical routine. An optimized method for the simultaneous quantitation of 12 major apolipoproteins (apos) combining on-line SPE and fast LC-MS/MS analysis in 6.5 min total run time was developed, reducing the manual sample pretreatment time of 3 μL serum or plasma by 60%. Within-run and between-day imprecisions below 10 and 15% (n = 10) and high recovery rates (94-131%) were obtained applying the high-throughput setup. High-quality porcine trypsin was used, which outperformed cost-effective bovine trypsin regarding digestion efficiency. Comparisons with immunoassays and another LC-MS/MS assay demonstrated good correlation (Pearson's R: 0.81-0.98). Further, requirements on sample quality concerning sampling, processing, and long-term storage up to 1 year were investigated revealing significant influences of the applied sampling material and coagulant on quantitation results. Apo profiles of 1339 subjects of the LIFE-Adult-Study were associated with lifestyle and physiological parameters as well as establish parameters of lipid metabolism (e.g., triglycerides, cholesterol). Besides gender effects, most significant impact was seen regarding lipid-lowering medication. In conclusion, this novel highly standardized, high-throughput targeted proteomics assay utilizes a fast, simultaneous analysis of 12 apos from least sample amounts.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  apolipoproteins; confounding variables; preanalytics; quantitative proteomics; targeted proteomics

Mesh:

Substances:

Year:  2018        PMID: 29280342     DOI: 10.1002/pmic.201700279

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  8 in total

1.  A high-throughput mass spectrometry-based assay for large-scale profiling of circulating human apolipoproteins.

Authors:  Valentin Blanchard; Damien Garçon; Catherine Jaunet; Kevin Chemello; Stéphanie Billon-Crossouard; Audrey Aguesse; Aya Garfa; Gilles Famchon; Amada Torres; Cédric Le May; Matthieu Pichelin; Edith Bigot-Corbel; Gilles Lambert; Bertrand Cariou; Samy Hadjadj; Michel Krempf; Kalyane Bach-Ngohou; Mikaël Croyal
Journal:  J Lipid Res       Date:  2020-05-13       Impact factor: 5.922

2.  Simultaneous LC/MS/MS quantification of eight apolipoproteins in normal and hypercholesterolemic mouse plasma.

Authors:  Richard Wagner; Julia Dittrich; Joachim Thiery; Uta Ceglarek; Ralph Burkhardt
Journal:  J Lipid Res       Date:  2019-02-05       Impact factor: 5.922

3.  Simultaneous Mass Spectrometry-Based Apolipoprotein Profiling and Apolipoprotein E Phenotyping in Patients with ASCVD and Mild Cognitive Impairment.

Authors:  Ilijana Begcevic Brkovic; Benedikt Zöhrer; Markus Scholz; Madlen Reinicke; Julia Dittrich; Surab Kamalsada; Ronny Baber; Frank Beutner; Andrej Teren; Christoph Engel; Kerstin Wirkner; Holger Thiele; Markus Löffler; Steffi G Riedel-Heller; Uta Ceglarek
Journal:  Nutrients       Date:  2022-06-15       Impact factor: 6.706

Review 4.  Applications of Tandem Mass Spectrometry (MS/MS) in Protein Analysis for Biomedical Research.

Authors:  Anca-Narcisa Neagu; Madhuri Jayathirtha; Emma Baxter; Mary Donnelly; Brindusa Alina Petre; Costel C Darie
Journal:  Molecules       Date:  2022-04-08       Impact factor: 4.927

Review 5.  The Potential of 'Omics to Link Lipid Metabolism and Genetic and Comorbidity Risk Factors of Alzheimer's Disease in African Americans.

Authors:  Kaitlyn E Stepler; Renã A S Robinson
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 6.  Apolipoprotein profiling as a personalized approach to the diagnosis and treatment of dyslipidaemia.

Authors:  L Renee Ruhaak; Arnoud van der Laarse; Christa M Cobbaert
Journal:  Ann Clin Biochem       Date:  2019-03-19       Impact factor: 2.057

7.  The Mean ApoC1 Serum Level in Postoperative Samples from Neurosurgical Patients Is Lower than in Preoperative Samples and during Chemotherapy.

Authors:  Michelle Hilbert; Peter Kuzman; Wolf C Mueller; Ulf Nestler
Journal:  Biology (Basel)       Date:  2022-07-07

8.  Feasibility of ApoC1 serum levels as tumor biomarker in glioblastoma patients: a pilot study.

Authors:  Michelle Hilbert; Peter Kuzman; Wolf C Mueller; Jürgen Meixensberger; Ulf Nestler
Journal:  Sci Rep       Date:  2022-10-10       Impact factor: 4.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.